37 results
8-K
EX-10.1
AUPH
Aurinia Pharmaceuticals Inc
21 Sep 23
Aurinia Board of Directors Appoints Dr. Robert T. Foster as New Board Director
4:06pm
of or economic exposure to any Voting Securities or engage in any swap or hedging transaction, or other derivative agreement of any nature with respect … to sell, directly or indirectly, through swap or hedging transactions or otherwise, all or substantially all, voting rights decoupled from
DEF 14A
emx08w1m
10 May 21
Definitive proxy
4:06pm
PRE 14A
lz7o20g9o2uxtl
27 Apr 21
Preliminary proxy
4:32pm
10-K
ltkp8qaq2d9i
24 Feb 21
Annual report
4:09pm
SUPPL
1oxl 2t5tupz2oyzegpj
23 Jul 20
Supplemental materials (foreign)
4:06pm
SUPPL
dygzy4g6il8j7hhqz1k
26 Jun 20
Supplemental materials (foreign)
4:08pm
F-10/A
bsqaviia
17 Jun 20
Registration of securities (Canada) (amended)
4:35pm
F-10
ox9xvrows1s3 psj
29 May 20
Registration of securities (Canada)
4:07pm
6-K
EX-99.3
csmobli
28 Apr 20
Notice of Annual General and Special Meeting of Shareholders
4:30pm
SUPPL
tpkrf 59buqn
10 Dec 19
Supplemental materials (foreign)
4:31pm
SUPPL
2lkmidr0
9 Dec 19
Supplemental materials (foreign)
6:35am
SUPPL
n5ec hwql2naile2fmc
13 Sep 19
Supplemental materials (foreign)
5:05pm
6-K
EX-99.2
wfkku5 wwuredxsg
31 May 19
Notice of Annual General Meeting of Shareholders
8:26am
40-F
EX-99.2
co65qn3 qx6j
19 Mar 19
Annual report (Canada)
4:16pm
40-F
EX-99.3
gq3ausn1u u0eelqe8dz
19 Mar 19
Annual report (Canada)
4:16pm